Nearly 80 million Americans are currently infected with HPV, and men account for a substantial share of new infections every year — yet vaccination rates among adult males remain far lower than among women. That gap is not about biology. It is about a persistent myth: that the HPV vaccine is a women’s vaccine. It is not.
The HPV vaccine for men (specifically Gardasil 9, the only HPV vaccine currently available in the United States) protects against genital warts and the HPV strains responsible for most anal, penile, and throat cancers. It is recommended for males starting at age 11–12, with catch-up dosing generally available through age 26 and shared decision-making with a doctor up to age 45. Critically, the vaccine prevents new infections — it does not treat or clear HPV you already have. If you have recently been diagnosed, it can still protect you against the strains you have not yet encountered.
For a broader foundation on how the vaccine works, see The HPV Vaccine: How It Works, Who Should Get It, and Whether It’s Safe. This article focuses specifically on men.
Table of Contents
Key Takeaways
- The HPV vaccine for men is just as effective as it is for women — the “women’s vaccine” label is outdated and inaccurate.
- Gardasil 9 protects against genital warts and the HPV types behind most anal, penile, and oropharyngeal (throat) cancers.
- Vaccination is routine at ages 11–12, with catch-up generally through 26 and shared decision-making up to 45 — verify current guidance with your provider or the CDC.
- If you already have HPV, the vaccine will not clear your current infection, but it can protect you against other covered strains you have not yet been exposed to.
- The safety profile in men mirrors that in women: mild, short-lived side effects are common; serious adverse events are rare.
Quick Answer
Men benefit from the HPV vaccine (Gardasil 9) just as women do — it prevents genital warts and the HPV types behind most anal, penile, and throat cancers. It is routine at ages 11–12, with catch-up generally through 26 and shared decision-making up to 45. It prevents new infections but will not treat or clear HPV you already have.
Should Men Get the HPV Vaccine?
Yes — without qualification.
For years, public messaging around HPV vaccination centered on girls and cervical cancer. That framing left men out of the conversation, and vaccination rates among males suffered as a result. The science, however, has always been clear: men are both carriers and victims of HPV-related disease.
HPV is transmitted through skin-to-skin sexual contact. Men can carry high-risk strains without symptoms, pass them to partners, and simultaneously develop serious HPV-related cancers themselves. There is no male equivalent of a Pap smear to screen for HPV-related cell changes in the throat, anus, or penis — which makes prevention through vaccination even more important for men than it might initially seem.
The Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO), and the NHS all recommend HPV vaccination for males. This is not a fringe position or a new one. The FDA approved Gardasil for males in 2009. The evidence base has only grown since then.
To understand the full picture of how HPV affects men specifically — including symptoms, risks, and testing — see HPV in Men: Symptoms, Risks, Testing, and What It Means.
What the HPV Vaccine Protects Men Against
Gardasil 9 targets nine HPV strains. For men, the protection covers three main disease categories:
Genital Warts
HPV types 6 and 11 cause approximately 90% of all genital warts. These are low-risk strains — they do not cause cancer — but genital warts can be painful, recurring, and emotionally distressing. Gardasil 9 covers both types. For more detail on what genital warts look like and how they are managed, see Genital Warts: What They Are, What They Look Like, and What to Do.
Anal Cancer
Men who have sex with men (MSM) face a significantly elevated risk of anal cancer, but HPV-related anal cancer also occurs in heterosexual men. HPV types 16 and 18 — both covered by Gardasil 9 — are responsible for the majority of anal cancer cases. A landmark clinical trial (the “FUTURE II” male study, published in the New England Journal of Medicine, PMID: 21288094) demonstrated that Gardasil was highly effective at preventing anal intraepithelial neoplasia (precancerous lesions) in men who have sex with men.
Penile Cancer
Penile cancer is relatively rare, but HPV is detected in roughly 40–50% of cases. Types 16 and 18 are the most common culprits. While penile cancer does not receive the same public attention as cervical cancer, the consequences — including partial or total penectomy in advanced cases — are severe. Vaccination offers a meaningful layer of protection.
Oropharyngeal (Throat) Cancer
This is the fastest-growing HPV-related cancer category in men. Oropharyngeal cancer — cancer of the back of the throat, base of the tongue, and tonsils — now occurs more frequently in men than in women, and HPV type 16 is the primary driver. There is no routine screening test for HPV-related throat cancer, which makes vaccination the most powerful tool available. The connection between HPV and cancer more broadly is covered in HPV and Cancer: Which Cancers Are Linked, How It Happens, and How It’s Prevented.
Key cancers and conditions Gardasil 9 protects men against:
| Condition | HPV Types Covered | Notes |
|---|---|---|
| Genital warts | 6, 11 | ~90% of cases caused by these types |
| Anal cancer | 16, 18, 31, 33, 45, 52, 58 | Elevated risk in MSM; also affects heterosexual men |
| Penile cancer | 16, 18 | HPV detected in ~40–50% of cases |
| Oropharyngeal cancer | 16 | Fastest-growing HPV cancer in men |
| Recurrent respiratory papillomatosis | 6, 11 | Rare but serious airway condition |
At What Age Can Men Get the HPV Vaccine?
The standard schedule in the United States, per CDC guidance, is:
- Ages 11–12: Routine vaccination (two-dose series, given 6–12 months apart)
- Ages 13–26: Catch-up vaccination for those not previously vaccinated (two or three doses depending on age at first dose)
- Ages 27–45: Shared clinical decision-making — discuss with your doctor whether vaccination is appropriate based on your individual risk factors
Important: Age recommendations, dosing schedules, and eligibility criteria can change. Always verify current guidance directly with the CDC (cdc.gov), NHS (nhs.uk), or your healthcare provider. Do not rely solely on any single article, including this one.
Men who are immunocompromised — including those living with HIV — may have different recommendations and should discuss vaccination timing carefully with their physician.
Does the HPV Vaccine Help If You Already Have HPV?
This is the question most men recently diagnosed with HPV ask first, and it deserves a direct answer.
The vaccine will not treat or clear an HPV infection you already have. It is not a therapeutic vaccine. It does not stimulate the immune system to eliminate an existing infection. If you have already been exposed to HPV type 16, for example, Gardasil 9 will not remove that virus from your body.
However — and this is important — the vaccine can still benefit you if you have HPV.
Gardasil 9 covers nine strains. The statistical likelihood that any one person has been exposed to all nine is low, particularly in younger adults. If you have been diagnosed with one strain, you are probably not infected with all the others. Vaccination can protect you against the covered strains you have not yet encountered.
This is why the CDC and most clinical guidelines do not recommend HPV testing before vaccination. The vaccine is recommended based on age and risk, not on confirmed HPV status.
For information on what HPV testing can and cannot tell you, see HPV Testing: How It Works, Who Should Get It, and What Your Results Mean.
“Getting vaccinated after a diagnosis still makes sense — think of it as closing the doors you haven’t opened yet.”
If you are exploring other options alongside vaccination, including immune-support supplements that have been studied in the context of HPV, see AHCC for HPV: What It Is, What the Evidence Shows, and What It Doesn’t for an evidence-based overview.
Is the HPV Vaccine Safe for Men?
Yes. The safety profile of Gardasil 9 in men is consistent with its profile in women, and both are well-established after more than 15 years of post-market surveillance involving hundreds of millions of doses worldwide.
Common side effects (mild and temporary):
- Pain, redness, or swelling at the injection site
- Headache
- Fatigue
- Mild fever
- Dizziness or fainting shortly after injection (common with all injections — sit or lie down for 15 minutes afterward)
Serious adverse events are rare. The Vaccine Adverse Event Reporting System (VAERS) and independent post-market studies have not identified any pattern of serious harm linked to Gardasil 9 in males.
The vaccine does not contain live virus. It cannot give you HPV. It is made from virus-like particles (VLPs) — protein shells that mimic the outer surface of HPV without any genetic material.
Men with known allergies to yeast or any vaccine component should discuss this with their provider before vaccination.
Where Men Can Get the HPV Vaccine and What It Costs
HPV vaccination for men is available through:
- Primary care physicians and family doctors
- Pediatricians (for adolescents)
- Sexual health clinics and STI clinics
- Community health centers
- Some pharmacies (eligibility varies by age and location)
Cost varies significantly by country, insurance status, and age. In the United States, the Vaccines for Children (VFC) program covers HPV vaccination at no cost for eligible individuals through age 18. Many private insurance plans cover the vaccine for adults through age 26. Coverage for ages 27–45 is less consistent — check with your insurer directly.
In the United Kingdom, the NHS offers HPV vaccination free of charge to males through age 25 via the national immunization program, including catch-up for MSM up to age 45.
Do not rely on any article for current pricing or coverage details. Verify with your provider, insurer, or national health authority.
Frequently Asked Questions
Should men get the HPV vaccine?
Yes. The CDC, WHO, and NHS all recommend HPV vaccination for males. It protects against genital warts and several cancers, including anal, penile, and throat cancers. The idea that it is a “women’s vaccine” is a myth.
What does the HPV vaccine protect men against?
Gardasil 9 protects men against genital warts (HPV 6, 11) and the high-risk strains responsible for most anal, penile, and oropharyngeal cancers (HPV 16, 18, and five others).
Is it too late if I’m sexually active or already have HPV?
Not necessarily. If you are within the recommended age range, vaccination is still advised. If you already have HPV, the vaccine will not clear your current infection, but it can protect you against the covered strains you have not yet been exposed to.
Is the HPV vaccine safe for men?
Yes. Gardasil 9 has been studied in males since before its 2009 FDA approval and monitored extensively since. Common side effects are mild and temporary. Serious adverse events are rare.
Up to what age can men get the HPV vaccine?
Routine catch-up vaccination is generally recommended through age 26. Shared decision-making with a provider is recommended for ages 27–45. Verify current CDC or NHS guidance, as recommendations can be updated.
Conclusion
The HPV vaccine for men is one of the most effective cancer-prevention tools available — and one of the most underused. Gardasil 9 protects against genital warts and the HPV strains behind the majority of anal, penile, and oropharyngeal cancers. It is safe, well-studied, and recommended by every major health authority.
If you have recently been diagnosed with HPV, the vaccine will not clear your current infection. That is a firm boundary. But it can still protect you against the other covered strains you have not yet encountered — and that protection is real and meaningful.
Actionable next steps:
- Talk to your doctor or a sexual health clinic about whether you are within the recommended age range for vaccination.
- If you are ages 27–45, ask specifically about shared decision-making and your individual risk factors.
- Verify current dosing schedules and cost coverage through the CDC (cdc.gov) or your national health authority.
- Explore HPV treatment options if you have already been diagnosed and want to understand what management looks like.
- Do not wait for symptoms. Most HPV infections cause none — and the vaccine works best before exposure to the strains it covers.
References
- Centers for Disease Control and Prevention. HPV Vaccination Recommendations. https://www.cdc.gov/hpv/hcp/schedules/index.html
- World Health Organization. Human papillomavirus (HPV) and cervical cancer. https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer
- NHS. HPV vaccine overview. https://www.nhs.uk/conditions/vaccinations/hpv-human-papillomavirus-vaccine/
- Palefsky JM, et al. “HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia.” New England Journal of Medicine. 2011;365(17):1576–1585. PMID: 21288094. DOI: 10.1056/NEJMoa0908748
- Giuliano AR, et al. “Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males.” New England Journal of Medicine. 2011;364(5):401–411. PMID: 21288094. DOI: 10.1056/NEJMoa0909537
- U.S. Food and Drug Administration. Gardasil 9 Prescribing Information. https://www.fda.gov/vaccines-blood-biologics/vaccines/gardasil-9
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis, treatment, and vaccination decisions specific to your situation.
Author: Dr. Laura Bennett, OB/GYN — Board-Certified Gynecologist, Women’s Integrative Health Center (Private Practice) | Sources: WHO, CDC, ACOG, NHS, NCI
